News

PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults

PCSK9 inhibitor lowers risk of first heart attack and stroke in high-risk adults

Credit: Pixabay/CC0 Public Domain Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients’ treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the American Heart Association Scientific Sessions

Stenting all blocked arteries outperforms culprit-only treatment approach, study shows

Stenting all blocked arteries outperforms culprit-only treatment approach, study shows

Credit: Unsplash/CC0 Public Domain Opening all blocked arteries with stents in patients with a heart attack, known as complete revascularization, reduces the risk of death from cardiovascular causes, death from any cause and future heart attacks compared with opening only the culprit artery causing the heart attack according to a new, large international study led

ENCIRCLE trial transforms treatment of mitral regurgitation

ENCIRCLE trial transforms treatment of mitral regurgitation

Credit: Pixabay/CC0 Public Domain David Daniels, M.D., an interventional cardiologist with Sutter West Bay Medical Group and structural heart section chief of Sutter’s Advanced Heart & Vascular Service Line, presented results of the international ENCIRCLE clinical trial at the Transcatheter Cardiovascular Therapeutics conference in San Francisco, Calif. The findings were simultaneously published in The Lancet

Drug prevents congenital heart block recurrence in a high-risk pregnancy

Drug prevents congenital heart block recurrence in a high-risk pregnancy

Congenital heart block, sometimes referred to as cardiac neonatal lupus, is a rare but potentially life-threatening condition that affects babies born to mothers with specific autoantibodies—called anti-SSA/Ro antibodies—which can attack the fetal heart via its electrical conduction system, leading to a slower heart rate. Most surviving infants with congenital heart block eventually require a pacemaker